M. D. Ponce Salazar

M. D. Ponce Salazar

Auto-generated profile, based on publicly available information

M. D. Ponce Salazar

AVivanco International S.A.C., Lima, Lima, Peru

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Animal Reproduction Science
Verified
Journal Article
Closed access
CSCalogero Stelletta
Calogero Stelletta
NJN.S. Juyena
N.S. Juyena
DSD. Ponce Salazar
D. Ponce Salazar
JRJ. Ruiz
J. Ruiz
Gustavo A. Gutiérrez-ReynosoGustavo A. Gutiérrez-Reynoso
Gustavo A. Gutiérrez-Reynoso

2 December 2019 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
JLJ. Lutz
J. Lutz
SJS. Johnson
S. Johnson
KDK. Duprey
K. Duprey
PTP. Taylor
P. Taylor
HVH. Vivanco
H. Vivanco
CYC. Youngs
C. Youngs
The alpaca (Vicugna pacos) is a ruminant livestock species in the South American camelid family. There are more than 9 million South American camelids globally that make important contributions to the livelihoods of rural farmers through conversion of low quality roughages to high quality food and fibre. Reproductive biotechnologies for alpacas are not well developed compared with those for other ruminant livestock species. In particular, embryo cryopreservation technologies are lacking. The objective of this study was to evaluate under field conditions a vitrification protocol originally developed for old world camels that we adapted for use in alpacas. Potential donors were evaluated for follicular development using a 7.5-MHz ultrasound probe. Hembras (sexually mature female alpacas) with ovarian follicles 7-10 mm in diameter were behaviour tested to determine sexual receptivity, and receptive females were naturally mated to a proven herd sire. At the time of breeding, non-superovulated donors (n = 4) received 30 μg gonadorelin. Embryos were nonsurgically collected 7 days after breeding and handled at 20°C. Diameter of harvested embryos (n = 4 quality grade 1 hatched expanded blastocysts) was measured using an eyepiece reticle. All recovered embryos were placed individually into 0.5-mL drops of vitrification solution (VS1: 1.4 M glycerol) for 5 min, 0.5-mL drops of VS2 (1.4 M glycerol + 3.6 M ethylene glycol) for 5 min, 0.05-mL drops of VS3 (3.4 M glycerol + 4.6 M ethylene glycol) for 20 s, and 0.05-mL drops of VS3 for 20 s while loading into open-pulled straws (OPS). Each OPS was plunged directly into liquid nitrogen for storage for 29 days. At warming, each OPS was submerged into a 1-mL drop of warming solution 1 (WS1: 0.5 M galactose) for 1 min followed by 1 min in WS2 (0.25 M galactose) for 5 min before being incubated at 37°C in 5% CO2 in humidified air for 21 h in 1 mL of Syngro holding medium supplemented with 10% (vol/vol) alpaca serum. Embryos that grew during culture (n = 2) were transferred individually into synchronous recipients, and embryos that did not appear to grow (n = 2) were transferred together as a pair. Prior to embryo transfer, potential recipients were evaluated ultrasonographically as described previously. Hembras with ovarian follicles 7-10 mm in diameter were behaviour tested, and sexually receptive females received 30 μg gonadorelin 6 days before embryo transfer. Final selection of recipients (n = 3) was based on presence of a corpus luteum and nonreceptive behaviour to a herd sire 24 h before transfer. Pregnancy was detected ultrasonographically, and fetal heartbeat was detected 29 days post-transfer in one of the three recipients. Ultrasound at 177 days post-transfer revealed that the pregnancy, generated from a 400 μm × 375 μm vitrified-warmed embryo that had grown in culture, was still ongoing. If this pregnancy results in the birth of a live cria (newborn alpaca), it would represent-to the best of our knowledge-the world's first cria born from a cryopreserved alpaca pre-implantation embryo. It would also demonstrate the potential utility of this protocol under field conditions.

3 December 2018 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
HVH. W. Vivanco-Mackie
H. W. Vivanco-Mackie
MPM. D. Ponce-Salazar
M. D. Ponce-Salazar
MMM. Miguel-Gonzales
M. Miguel-Gonzales
CYC. R. Youngs
C. R. Youngs
CJC. Jara
C. Jara
MAM. Asparrin
M. Asparrin
The objective of this study was to compare the effectiveness of cryopreserving in vivo-produced alpaca embryos by slow freezing v. vitrification. The embryos were produced from 9 female alpacas at Fundo Mallkini, Puno, Peru, located at 4300 m elevation. The donor alpacas were synchronized by induction to ovulate with an injection of gonadotropin-releasing hormone (0.0084 mg of buserelin acetate) and natural mating with vasectomized males to male receptive donors (day of ovulation induction was considered Day 0). On Day 2, the donors were injected 700 IU of eCG. On Day 7, the donors received an injection of prostaglandin F2a (0.25 mg of cloprostenol) and were mated on Day 8 by fertile males (2 matings 12 h apart: 0600 and 1800 h). The embryos were collected at 5.5 days after fertile mating and were graded as per IETS recommendations; most of the embryos were already expanded and hatched blastocysts. Embryos were washed and maintained in holding medium (1 L PBS + 1 g Glucose + 36 mg sodium pyruvate + 0.4% BSA + 50 mg kanamycin monosulfate) at 23°C for up to 1 h and distributed into 2 groups for either slow freezing for direct transfer (n = 14 embryos) or vitrification (n = 10 embryos). Slow freezing consisted of transfer into freezing medium (9 mL of 1.5 M ethylene glycol + 1 mL of 1.0 M sucrose prepared in holding media) at 23°C, placing in 0.25-mL straws and subjected to freezing at a rate of -0.5°C/ minute to -35°C and then plunging into LN. Vitrification followed a procedure described for camel embryos whereby embryos were exposed to solutions containing increasing amounts of glycerol and ethylene glycol for fixed periods and were then loaded into an open pull straw and plunged directly into LN for storage. The cryopreserved embryos were transferred into adult alpacas at the Community of Suitucancha, Junin, Peru (1500 km from the farm where the embryos were collected and cryopreserved, 4200 m elevation). Embryos in the slow-freezing group were thawed in warm water at 37°C for 30 s and loaded directly into the embryo transfer gun for direct transfer into 7 alpaca recipients (2 embryos per recipient). Vitrified embryos were warmed by removing the open pull straw from the LN and transferring the embryos to 2 warming solutions at 37°C with decreasing levels of vitricants and containing 0.5 M galactose with a final incubation at room temperature in holding media and then transferred into 5 alpaca recipients (2 embryos per recipient). The embryos were transferred into synchronized recipients by transcervical nonsurgical method. Pregnancy diagnosis was made by transrectal ultrasound examination at 45 days post-transfer. The pregnancy rates in the slow-freezing and vitrification groups, respectively, were 2/7 (29%) and 0/5 (0%); the difference was not significant (P > 0.05) based on Fisher’s exact test. Twin pregnancies were not detected. We consider the result with slow freezing very promising, as in previous trials we had less than 18% pregnancies. More trials with larger number of embryos per cryopreservation method are being programmed.

4 December 2017 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
HVH. W. Vivanco-Mackie
H. W. Vivanco-Mackie
MSM. D. P. Salazar
M. D. P. Salazar
MMM. Miguel-Gonzales
M. Miguel-Gonzales
CYC. R. Youngs
C. R. Youngs
MAM. Asparrin
M. Asparrin
The aim of the study was to improve the pregnancy rate in recipient alpacas using nonsteroidal anti-inflammatpry druds (NSAIDs) at time of embryo transfer. Because most NSAIDs are non-selective inhibitors of cyclooxygenases, which are the rate-limiting enzymes in the formation of prostaglandins, such treatment could temporarily block the production of prositaglandin F2a (PGF2a) and hence maintain corpus luetum (CL) activity long enough to support embryo development and pregnancy. The experiment was carried out in the Peruvian southern highlands (4,100 m elevation). Thirty-one adult alpaca donors were subjected to superovulation and embryo flushing as described previously (Vivanco-Mackie 2013 Proc. 29th Annu. Mtg. AETE, Istanbul, pp. 43-74; http://www.aete.eu/index.php/publications-aete/proceedings/2013/file). From the collected embryos, 20 grade A embryos were selected and transferred fresh into the recipients of the 2 experimental groups. All embryos were collected and transferred at 6.5 days post-mating of the donors with one embryo transferred per recipient. Recipient alpacas (n = 20) were synchronized and induced to ovulate after a selection made by ultrasonography, selecting as recipients the alpacas with follicles >8 mm and then exposing them to vasectomized males followed by IM injection of gonadotropin-releasing hormone (GnRH, 0.0084 mg of acetate of buserelin). Embryo transfers were made by laparoscopically aided laparotomy 6.5 days after ovulation induction as this method has been demonstrated to be more effective in previous trials compared with transcervical non-surgical transfers. At the time of embryo transfer, the recipients were randomly assigned to 1 of the 2 treatments according to the NSAID injected immediately after embryo transfer: Treatment 1 (10 alpacas) was an IM injection of meloxicam at 0.5 mg/kg of body weight; treatment 2 (10 alpacas) was an IM injection of tolfenamic acid at 3 mg/kg of body weight. At the pregnancy test by ultrasound scanning on Day 58 post-transfer, 30% (3/10) of the recipients had a live fetus in treatment 1, whereas treatment 2 had only 10% (1/10).The difference was not significant (P > 0.05) based on Chi-squared analysis. Th historical pregnancy rate obtained with fresh embryos transferred using the same technique and on the same farm where the comparison between NSAIDs was performed was 28.6% at 58 days post-transfer (Vivanco-Mackie et al. 2015 Reprod. Fertil. Dev. 27, 173 abst). Results suggest that there is no difference between tolfenamic acid and meloxicam in their effect on pregnancy rates in alpacas receiving fresh embryo transfers. Compared with historical data of nontreated recipients, results of the present experiment may indicate that the use of NSAIDs at the time of embryo transfer does not improve pregnancy rates in alpaca fresh embryo recipients. However, additional research studies with greater numbers of recipients and an untreated control group are necessary to confirm the preliminary results of the present study. The study was funded by the ‘INNOVATE PERU’ program of the Peruvian Government.

7 December 2010 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
WVW. Vivanco
W. Vivanco
EHE. Huaman
E. Huaman
SLS. Leon
S. Leon
TNT. Nunez
T. Nunez
AGA. Gregoire
A. Gregoire
MAM. Asparrin
M. Asparrin
Alpacas are animals with induced ovulation, andthey show high individual variation in the symptoms, duration, and regularity of oestrus or period of female receptivity to males; their follicular phase does not end in ovulation and subsequent luteal phase unless an external stimulation such as copulation or exogenous application of an ovulation inducing hormone is applied. The objective of the present study was to compare the use of eCG v. porcine (p)FSH as superovulatory hormones for the in vivo production of embryos in alpacas that were selected as being receptive to the male and were treated with an ovulation-inducing hormone to generate a luteal phase. Twenty adult (3 to 5 years old) female alpacas, located at Mallkini, Puno, Peru (at 4100 m elevation), were used for the trial. A group of females was exposed to males to test for breeding receptivity; 20 alpacas were receptive, adopting copulatory position. Each of the selected females received 3.75 mg of LH IM (Lutropin®, Bioniche Animal Health, Belleville, ON, Canada). Day 0 was then considered the date of LH injection. The 20 alpacas were then distributed into 2 treatments: Treatment 1 (T1 = 10 alpacas) received on Day 2, 1000 IU of eCG IM (Pregnecol®, Bioniche Animal Health) and on Day 7, a dose of PGF2a IM (0.263 mg of cloprostenol; Ciclar®, Andeanvet-Zoovet, Lima, Peru). Treatment 2 alpacas (T2 = 10 alpacas) received from Day 2 and up to Day 5, at 12-h interval, decreasing doses of pFSH IM (100 mg; Folltropin V®, Bioniche Animal Health) for 4 days, and on Day 7, a dose of PGF2a IM (0.263 mg of cloprostenol; Ciclar®, Andeanvet-Zoovet). All alpacas from T1 and T2 were mated twice with fertile males, the first mating at 24 h after the injection of PGF2a and the second at 12 h after the first mating. All females received a dose of GnRH IM (0.0084 mg of buserelin; Buserelina®, Andeanvet-Zoovet) at time of first mating. The embryos in both treatments were collected 6.5 days after the first mating by nonsurgical transcervical embryo flushing. There were no significant differences in the mean number of blastocysts collected per treatment (P > 0.05), being 3.0 ± 2.87 blastocyst for T1 and 1.6 ± 2.67 for T2. The number of blastocysts per treatment was 30 and 16 for T1 and T2, respectively. The results show that superovulatory treatment with eCG is more effective for the production of viable blastocysts than treatment with pFSH in alpacas treated for superovulation during the luteal phase. This work was partially funded by Bioniche Animal Health.

4 December 2014 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
HVH. W. Vivanco-Mackie
H. W. Vivanco-Mackie
MSM. D. P. Salazar
M. D. P. Salazar
MMM. Miguel
M. Miguel
CYC. Youngs
C. Youngs
MAM. Asparrin
M. Asparrin
The objective of the study was to determine the embryo survival up to calving of fresh and cryopreserved (frozen and vitrified) alpaca embryos transferred into alpaca recipients by nonsurgical transcervical embryo transfer and by surgical laparoscopically aided embryo transfer. For this report we have compiled the information from 127 embryo transfers in alpacas done by our group at Mallkini, Puno, Peru, at 4200 m elevation. The embryos have been collected from superovulated donor alpacas flushed at 6.5 days post mating, some were transferred as fresh and some were cryopreserved; the recipients (3 to 7 years old) were selected based on presence of functional corpora lutea at ecosonographic examination and subjected to ovarian cycle synchronization and ovulation induction as per Vivanco (2013). From a total of 133 alpacas selected, 127 were used, from which 82 received fresh, 32 frozen, and 13 vitrified embryos. All embryos were classed as A-class expanded blastocysts at time of transfer. By nonsurgical transcervical embryo transfer, 33 embryos were transferred fresh, 22 were frozen/thawed embryos, and 13 were vitrified/warmed embryos. By surgical laparoscopically aided method, 49 embryos were transferred fresh and 10 embryos were frozen/thawed; no vitrified embryos were transferred by this method. Results are detailed in Table 1. Pregnancy losses occured at up to 9 weeks (63 days) of gestation, the heaviest loss occurs in the first 3 weeks. After 9 weeks of gestation, no losses were registered. In average, 22% of fresh embryos transferred were represented as crias born. None of the cryopreserved embryos survived up to 11 weeks post-transfer. There is no difference in percentage of crias born between nonsurgical transcervical embryo transfers and surgical laparoscopically aided embryo transfers.The heavy embryo losses could be related to nutrition and high-altitude limitations; however, it is difficult to make comparisons with others because reports to date lack information on the actual crias born from embryo transfers in alpacas; most of the reports are based on pregnancy reports up to 30 to 60 days post-transfers. To date, no births from cryopreserved alpaca embryos have been reported. Furher studies on causes of embryo/fetal losses are necessary. Table 1. Results of embryo transfer This study was financed by the Peruvian Fund for Innovation, Science and Technology (FINCYT).